Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$211M |
| 2 |
HOUS
Anywhere Real Estate
HOUS
|
+$145M |
| 3 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
+$132M |
| 4 |
Apple
AAPL
|
+$125M |
| 5 |
Omnicom Group
OMC
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.13B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$725M |
| 3 |
Microsoft
MSFT
|
+$443M |
| 4 |
AGN
Allergan Inc
AGN
|
+$318M |
| 5 |
EOG Resources
EOG
|
+$259M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.37% |
| 2 | Financials | 13.36% |
| 3 | Healthcare | 12.62% |
| 4 | Industrials | 10.45% |
| 5 | Energy | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Brookfield
BN
$110B
| $38.9M | 0.01% |
3,772,230
+1,018,716
| +37% | +$10.2M |
|
1052
iShares S&P GSCI Commodity-Indexed Trust
GSG
$932M
| $38.8M | 0.01% |
1,143,933
-819,536
| -42% | -$27.4M |
|
|
CIT
1053
DELISTED
CIT Group Inc.
CIT
| $38.8M | 0.01% |
847,207
+71,718
| +9% | +$3.24M |
|
1054
Verisk Analytics
VRSK
$23.5B
| $38.8M | 0.01% |
645,806
+10,433
| +2% | +$624K |
|
1055
Ziff Davis
ZD
$1.92B
| $38.7M | 0.01% |
874,951
+6,246
| +0.7% | +$261K |
|
|
CLC
1056
DELISTED
Clarcor
CLC
| $38.7M | 0.01% |
625,396
-3,062
| -0.5% | -$177K |
|
1057
Bio-Techne
TECH
$11.3B
| $38.7M | 0.01% |
1,670,916
-27,912
| -2% | -$617K |
|
1058
Flowers Foods
FLO
$1.52B
| $38.6M | 0.01% |
1,830,434
+24,535
| +1% | +$507K |
|
|
PCH
1059
DELISTED
PotlatchDeltic
PCH
| $38.5M | 0.01% |
929,305
-109,091
| -11% | -$4.28M |
|
1060
Children's Place
PLCE
$55.1M
| $38.3M | 0.01% |
771,629
+200
| +0% | +$9.7K |
|
1061
Oxford Industries
OXM
$538M
| $38.1M | 0.01% |
571,758
+25,408
| +5% | +$1.71M |
|
|
VISN
1062
Vistance Networks Inc
VISN
$2.67B
| $37.9M | 0.01% |
1,639,945
+572,705
| +54% | +$14.3M |
|
1063
Baidu
BIDU
$35.5B
| $37.8M | 0.01% |
202,460
-130,745
| -39% | -$21.4M |
|
1064
BioMarin Pharmaceuticals
BMRN
$13.6B
| $37.8M | 0.01% |
606,951
+5,371
| +0.9% | +$324K |
|
1065
Healthcare Services Group
HCSG
$1.43B
| $37.6M | 0.01% |
1,277,758
+21,682
| +2% | +$640K |
|
1066
Bank OZK
OZK
$5.69B
| $37.6M | 0.01% |
1,122,681
+45,729
| +4% | +$1.42M |
|
1067
GATX Corp
GATX
$6.34B
| $37.6M | 0.01% |
560,971
-4,876
| -0.9% | -$319K |
|
1068
A.O. Smith
AOS
$8.51B
| $37.5M | 0.01% |
1,513,296
+25,736
| +2% | +$618K |
|
1069
Carter's
CRI
$1.43B
| $37.5M | 0.01% |
544,119
+18,431
| +4% | +$1.34M |
|
1070
Brinker International
EAT
$10.5B
| $37.4M | 0.01% |
769,254
+36,038
| +5% | +$1.81M |
|
1071
Celldex Therapeutics
CLDX
$3.52B
| $37.2M | 0.01% |
151,953
+121,290
| +396% | +$27.4M |
|
|
VTLE
1072
DELISTED
Vital Energy
VTLE
| $37.2M | 0.01% |
60,032
-15,650
| -21% | -$8.87M |
|
|
THOR
1073
DELISTED
THORATEC CORPORATION
THOR
| $37.1M | 0.01% |
1,064,707
+376,265
| +55% | +$12.5M |
|
1074
Jazz Pharmaceuticals
JAZZ
$16B
| $37.1M | 0.01% |
252,108
-17,113
| -6% | -$2.37M |
|
1075
Littelfuse
LFUS
$11.4B
| $36.9M | 0.01% |
397,175
-21,510
| -5% | -$1.97M |
|
Similar funds
Bank of New York Mellon's Q2 2014 Portfolio in Review
As of Q2 2014, Bank of New York Mellon held 4,361 positions worth $372B, up 1.2% from $367B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bank of New York Mellon's Q2 2014 filing shows 182 new, 2,103 increased, 1,683 reduced and 213 closed positions. Its largest new stake was Navient: 6,891,839 shares worth $122M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $6.13B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q2 2014 buy was Navient: 6,891,839 shares worth $122M.
- Bank of New York Mellon added most to TJX Companies in Q2 2014, an estimated $211M increase.
- Bank of New York Mellon's biggest Q2 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.13B.
- Bank of New York Mellon fully exited Fidelity National Financial in Q2 2014, selling an estimated $240M.
- Bank of New York Mellon's ten largest holdings make up 14% of its $372B portfolio in Q2 2014.
- Bank of New York Mellon opened 182 new positions and closed 213 in Q2 2014.
- Bank of New York Mellon's portfolio value rose 1.2% quarter-over-quarter to $372B.
Based on Bank of New York Mellon's 13F filing for Q2 2014, filed 12 Aug 2014.